Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Amneal Pharmaceuticals Inc. (AMRX)

4.91   -0.07 (-1.41%) 02-14 16:00
Open: 4.96 Pre. Close: 4.98
High: 5.11 Low: 4.845
Volume: 710,359 Market Cap: 1529M
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. It operates through two segments, Generics and Specialty. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, manufacture, and sale of branded pharmaceutical products primarily for central nervous system disorders and parasitic infections. It also offers licensed and owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinsons Disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.106 - 5.138 5.138 - 5.161
Low: 4.924 - 4.964 4.964 - 4.992
Close: 4.859 - 4.916 4.916 - 4.956

Technical analysis

as of: 2020-02-14 4:26:32 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 5.99     One year: 6.63
Support: Support1: 4.23    Support2: 3.52
Resistance: Resistance1: 5.13    Resistance2: 5.68
Pivot: 4.79
Moving Average: MA(5): 5.02     MA(20): 4.86
MA(100): 3.88     MA(250): 6.46
MACD: MACD(12,26): 0.09     Signal(9): 0.09
Stochastic oscillator: %K(14,3): 70.64     %D(3): 72.20
RSI: RSI(14): 53.27
52-week: High: 14.79  Low: 2.27  Change(%): -65.0
Average Vol(K): 3-Month: 288266  10-Days: 95428

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
AMRX has closed below upper band by 35.3%. Bollinger Bands are 28.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2020-01-16
Should Value Investors Pick Amneal Pharma (AMRX) Stock Now?
Let's see if Amneal Pharmaceuticals (AMRX) stock is a good choice for value-oriented investors right now from multiple angles.

2019-12-12
Here’s Why Amneal Pharmaceuticals (AMRX) Stock Skyrocketed 50% Today
As the saying goes, good things come to those who wait, and following a year of decline, patience might finally be paying off … The post Here’s Why Amneal Pharmaceuticals (AMRX) Stock Skyrocketed 50% Today appeared first on Smarter Analyst .

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 134.10
Shares Float (M) 82.30
% Held by Insiders 13.07
% Held by Institutions 76.30
Shares Short (K) 5760
Shares Short P. Month (K)

Stock Financials

EPS -2.635
Book Value (p.s.) 1.630
PEG Ratio -3.70
Profit Margin -19.61
Operating Margin 4.54
Return on Assets (ttm) 1.2
Return on Equity (ttm) -85.3
Qtrly Rev. Growth -20.6
Gross Profit (p.s.) 5.494
Sales Per Share
EBITDA (p.s.) 2.350
Qtrly Earnings Growth
Operating Cash Flow (M) 312.24
Levered Free Cash Flow (M) 310.76

Stock Valuations

P/E -1.86
P/E Growth Ratio -0.01
P/BV 3.01
P/S 0.36
P/CF 2.11

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.